Navigation Links
Revolutionary Pill Cuts Risk of Breast Cancer

The next five to ten years may see the development of a new contraceptive pill that reduces breast cancer risk as well as heart disease. It also has the added benefit of eliminating periods. //

The Combined Pill, currently available to women around the world is a combination of estrogen and progesterone. Estrogen however increases the risk of breast cancer and heart problems such as deep vein thrombosis.

Another, progesterone only drug, currently available in Britain also carries a risk of breast cancer mainly because of the progesterone in it.

The revolutionary new Pill uses a class of compounds known as the Progesterone Receptor Modulators (PRMs). These PRMs prevent the secretion of progesterone, which helps to maintain pregnancy.

As it neither contains estrogen nor progesterone but rather blocks the production of the latter, risks of breast cancer and heart problems are significantly reduced. Unlike the currently available drugs this new Pill also stops periods completely.

The new Pill could also herald an era of freedom from premenstrual symptoms and even endometriosis.

Professor David Baird, emeritus professor of reproductive endocrinology at the University of Edinburgh, has revealed that these PRMs were clinically tested on small groups of women with positive results and minimal side effects.

Teams in Sweden, Chile and the US have also worked on similar projects with the same compounds.

However experts warn that pro-life groups and the US Bush administration were hampering progress on the development of the new Pill as the new compound was developed on the basis of the RU486 abortion pill.

Pharmaceutical companies were also reluctant to market this drug for the very same reason.

Scientists claim that the development of this new Pill could bring transformations for millions of women. It would also reduce the risks of breast cancer and heart pr oblems, which accompany the currently available contraceptive pills.


'"/>




Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. A Revolutionary New Treatment For Cancer Available In Australia
3. New Revolutionary Drug Could Stop the Spread of HIV
4. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
5. Revolutionary Net To Control Malaria
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. Consensus on "Combination Therapy" for Breast Cancer
10. Breast cancer treatment to be determined by gene test
11. Breast Feeding prevents obesity later on in life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Diego, Ca (PRWEB) , ... April 28, 2017 , ... ... property management industry in the coastal communities. After Tina Howe joined the team, the ... and happy employees, honest services at affordable rates, and giving back to the San ...
(Date:4/28/2017)... UTAH (PRWEB) , ... April 28, 2017 , ... ... Account Manager for the North East region. Côté has 20+ years of experience ... Prior to Phytomer, Côté worked with an array of high-end cosmetic brands, retail ...
(Date:4/28/2017)... ... , ... NuevaCare, a leading home care agency based in San Mateo, California, ... proud to announce information upgrades to its blog in the form of WordPress tags. ... such as home care (generally) as well as senior care and home care agency ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
(Date:4/27/2017)... Jacksonville, Florida (PRWEB) , ... April 27, 2017 , ... ... qualified candidates. But they will rapidly reject an outdated healthcare executive resume. , “If ... good look at your executive resume and wondering if it’s as ready as you ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: